Literature DB >> 3544812

Drug therapy of portal hypertension.

R J Groszmann.   

Abstract

Portal hypertension is the result of increased flow and increased resistance in the portal system. Pharmacological therapy is aimed at altering these factors by the use of vasoconstrictors to reduce flow and vasodilators to decrease intrahepatic resistance. The current status of pharmacological agents to achieve these effects is reviewed.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3544812

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  2 in total

1.  Extreme polyuria: decompensated diabetes mellitus and/or diabetes insipidus?

Authors:  F Delhaye; J L Vincent; F Fery; B Pirotte; J Unger
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

2.  Wedged hepatic venous pressure reflects portal venous pressure during vasoactive drug administration in nonalcoholic cirrhosis.

Authors:  T Iwao; A Toyonaga; M Ikegami; M Sumino; K Oho; M Sakaki; H Shigemori; M Nakayama; K Tanikawa
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.